CareDx Inc
NASDAQ:CDNA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.9
33.99
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
CareDx Inc
Wall Street
Price Targets
CDNA Price Targets Summary
CareDx Inc
According to Wall Street analysts, the average 1-year price target for
CDNA
is 33.37 USD
with a low forecast of 25.25 USD and a high forecast of 42 USD.
CDNA Last Price Targets
CareDx Inc
The latest public price target was made on Aug 19, 2024 by
Mark Massaro
from
BTIG
,
who expects
CDNA
stock to
rise by 31%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Mark Massaro
BTIG
|
40
USD
Upside 31% |
1 month ago
Aug 19, 2024
|
CareDx upgraded to Buy from Neutral at BTIG
TheFly
|
|
Bill Bonello
Craig-Hallum
|
40
USD
Upside 31% |
1 month ago
Aug 16, 2024
|
CareDx price target raised to $40 from $32 at Craig-Hallum
TheFly
|
|
Bill Bonello
Craig-Hallum
|
32
USD
Upside 5% |
2 months ago
Aug 1, 2024
|
CareDx price target raised to $32 from $22 at Craig-Hallum
TheFly
|
|
Mason Carrico
Stephens
|
15
USD
Downside 51% |
5 months ago
Apr 17, 2024
|
Stephens Reiterates Overweight Rating on CareDx, Inc (CDNA)
StreetInsider
|
Unknown Analyst
Goldman Sachs
|
29
USD
Downside 5% |
1 year ago
Feb 6, 2023
|
Goldman Sachs Maintains Buy on CareDx, Lowers Price Target to $29
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CDNA's stock price target?
Price Target
33.37
USD
According to Wall Street analysts, the average 1-year price target for
CDNA
is 33.37 USD
with a low forecast of 25.25 USD and a high forecast of 42 USD.
What is CareDx Inc's Revenue forecast?
Projected CAGR
12%
For the last 8 years the
compound annual growth rate for
CareDx Inc's revenue is
33%.
The projected
CAGR
for the next 3 years is
12%.
You don't have any saved screeners yet
